Feed Preview

Fast Growing

Tumor Vaccines

Tumor Vaccines diagram by Lightspring, Shutterstock
Lightspring, Shutterstock

Tumor vaccines offer the potential for preventing cancer in high-risk individuals, preventing disease relapse after diagnosis and initial therapy, and shifting the balance of the host-tumor interaction to mitigate the progression of advanced cancers. Discover the latest research on tumor vaccines here.

Top 20 most recent papers
Science Translational Medicine

Strong vaccine responses during chemotherapy are associated with prolonged cancer survival

Science Translational MedicineMarch 20, 2020
Cornelis J M MeliefSjoerd H van der Burg
PLoS Pathogens

Cervicovaginal microbiome and natural history of HPV in a longitudinal study

PLoS PathogensMarch 28, 2020
Mykhaylo UsykCosta Rica HPV Vaccine Trial (CVT) Group
British Journal of Cancer

Immune phenotype and histopathological growth pattern in patients with colorectal liver metastases

British Journal of CancerMarch 25, 2020
Stefan StremitzerStefan J Scherer
Translational Lung Cancer Research

Chromosomal rearrangements and their neoantigenic potential in mesothelioma

Translational Lung Cancer ResearchMarch 25, 2020
Aaron Scott MansfieldGeorge Vasmatzis
Proceedings of the National Academy of Sciences of the United States of America

Broad and thematic remodeling of the surfaceome and glycoproteome on isogenic cells transformed with driving proliferative oncogenes

Proceedings of the National Academy of Sciences of the United States of AmericaMarch 25, 2020
Kevin K LeungJames A Wells
The Journal of Infectious Diseases

HIV modifies the effect of tobacco smoking on oral human papillomavirus infection

The Journal of Infectious DiseasesMarch 27, 2020
Babatunde Y AlliNicolas F Schlecht
Frontiers in Immunology

Novel Peptide-Based PD1 Immunomodulators Demonstrate Efficacy in Infectious Disease Vaccines and Therapeutics

Frontiers in ImmunologyMarch 27, 2020
Vinayaka KotraiahGabriel M Gutierrez
Genome Medicine

Tracking cancer progression: from circulating tumor cells to metastasis

Genome MedicineMarch 21, 2020
Francesc Castro-Giner, Nicola Aceto
Asian Pacific Journal of Cancer Prevention : APJCP

National Cancer Control Program of Thailand

Asian Pacific Journal of Cancer Prevention : APJCPMarch 28, 2020
Weerawut Insamran, Suleeporn Sangrajrang
Cancer Treatment and Research

CAR T Cell Therapy Progress and Challenges for Solid Tumors

Cancer Treatment and ResearchMarch 28, 2020
Lawrence A SternSaul J Priceman
British Journal of Cancer

Global analysis of human glycosyltransferases reveals novel targets for pancreatic cancer pathogenesis

British Journal of CancerMarch 24, 2020
Rohitesh GuptaMoorthy P Ponnusamy

Immunotherapy for esophageal cancer: a 2019 update

ImmunotherapyMarch 27, 2020
Dimitrios SchizasTheodore Liakakos

See more papers from this feed

Related Feeds

CAR-T cells

Chimeric antigen receptor (CAR) T cells are cells that are genetically engineered to recognize and target specific proteins. The ability of these cells to recognize cancer antigens and eliminate tumor cells have transformed cancer immunotherapy approaches. Here is the latest research on CAR-T cells.

Cancer Immunotherapy

Cancer immunotherapy is an important field of research that is looking at controlling cancer and tumor growth by activating the individuals own immune system. Recent studies have utilized chimeric antigen receptor t-cell therapy, immune checkpoint inhibitors and neoantigen vaccines. Discover the latest research on cancer immunotherapy here.

Exosomes & Tumor Environment

Several studies have reported the role of exosomes as important mediators of angiogenesis, metastasis, and immune modulation. Exosomes also have the potential to be used as biomarkers for clinical predictions. Here is the latest research on exosomes and the tumor microenvironment.

Graft Rejection

Graft rejection occurs when the donor's grafted tissue is rejected by the recipient's immune system, destroying the transplanted tissue. Discover the latest research on graft rejection here.

Graft vs Host Disease

Graft-versus-host disease (GVHD) is a major cause of morbidity and mortality after allogeneic haematopoietic cell transplantation from unrelated donors. Here is the latest research.

Immune Therapies In Cancer

Immunotherapy in cancer is used to help the immune system fight against invading cancer cells. It is used to slow the progression of the disease and prevent metastasis while enhancing the immune response. There are different types, including monoclonal antibodies and checkpoint inhibitors. Here is the latest research on immune therapies in cancer.


Immuno-oncology (or cancer immunotherapy) is the artificial stimulation of the immune system to treat cancer, improving on the immune system's natural ability to fight cancer. It exploits the fact that cancer cells often have tumor antigens, molecules on their surface that can be detected by the antibody proteins of the immune system, binding to them. The tumor antigens are often proteins or other macromolecules. Normal antibodies bind to external pathogens, but the modified immunotherapy antibodies bind to the tumor antigens marking and identifying the cancer cells for the immune system to inhibit or kill. Discover the latest research on immuno-oncology here.


Immunosuppression trends for solid organ transplantation have undergone a perceptible shift over the past decade. Discover the latest research on immunosuppression here.

Metastatic Malignancy Treatments

Treatment of metastatic cancers depends on the type of cancer and the severity of the disease. The regime often includes medications such as chemotherapy or hormone therapy, but may also include immunotherapy, radiation therapy, surgery or a combination. Discover the latest research on metastatic cancer treatments here.

Tumor Evasion of the Immune System

Tumor evasion of the immune system includes cells that operate their own growth and develop various strategies to escape from immune surveillance. Discover the latest research on tumor evasion of the immune system here.

© 2020 Meta ULC. All rights reserved